Stock listing

OTC:PKTX ProtoKinetix, Inc. Stock

Follow ProtoKinetix, Inc. into a list and get an email when it puts out news.

Share price · OTC:PKTX

$0.0020 USD 0.0000 (0.0%)

Close on Nov 12, 2026

Past year -71.4% · daily closes, Nov 12, 2025 – Nov 12, 2026, adjusted for splits
Day range
$0.0020 – $0.0020 USDNov 12, 2026
Market cap
$823,260 USDAt the close on Nov 12, 2026 · price × 411.6M shares outstanding
52-week range
$0.0001 – $0.0124 USDLowest and highest trades, Nov 13, 2025 – Nov 12, 2026
Traded on an average day
$8 USDMedian day 0 shares · 49 days with no trades · last 3 months, Aug 12, 2026 – Nov 12, 2026
ProtoKinetix, Inc. logo

Daily closes

Last 3 months, Aug 12, 2026 – Nov 12, 2026 · OTC:PKTX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00200.00000.0%$0.0020$0.0020$0.00200
$0.00200.00000.0%$0.0020$0.0020$0.00200
$0.0020+0.0018+900.0%$0.0020$0.0020$0.00202,500
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.0002-0.0001-33.3%$0.0001$0.0002$0.00013,000
$0.00030.00000.0%$0.0003$0.0003$0.00030
$0.00030.00000.0%$0.0003$0.0003$0.00030
$0.00030.00000.0%$0.0003$0.0003$0.00030
$0.00030.00000.0%$0.0003$0.0003$0.00030
$0.00030.00000.0%$0.0003$0.0003$0.00030
$0.00030.00000.0%$0.0003$0.0003$0.000312,000
$0.00030.00000.0%$0.0003$0.0003$0.00030
$0.00030.00000.0%$0.0003$0.0003$0.00030
$0.00030.00000.0%$0.0003$0.0003$0.00030
$0.00030.00000.0%$0.0003$0.0003$0.00030
$0.0003-0.0001-25.0%$0.0003$0.0003$0.0003100
$0.0004+0.0002+100.0%$0.0004$0.0004$0.0004550,000
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.0002+0.0001+100.0%$0.0002$0.0002$0.0002160,000
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.0001-0.0001-50.0%$0.0001$0.0001$0.000150,000
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.0002230
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00025,000
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00026,000
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00021,000
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00021,000
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.000220,458
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.0002-0.0003-60.0%$0.0002$0.0002$0.000250,000
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.0005+0.0001+25.0%$0.0002$0.0005$0.0002400,000

Splits

1 split · OTC:PKTX · every price before a split is adjusted for it

DayRatioWhat
5-for-2Split
Ticker
OTC:PKTX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

What changed lately

Latest news

All ProtoKinetix, Inc. news

ProtoKinetix, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
3 in the last 12 months · 69 in all · newest Nov 5, 2026 · oldest 2009
Decks
4 decks · latest Feb 11, 2022

Valuation

Price/book 3.3× against a median of 0.3×: 10th lowest of 11 Biotechnology companies shown. Statements: Year to Dec 31, 2025 · balance Sep 30, 2026 · price Nov 12, 2026

Enterprise value
$822,736 USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
3.3×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
0.61

Biotechnology: the 10 companies nearest in size, of 891 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
ProtoKinetix, Inc. · OTC:PKTXUS$823,260US$822,736n/an/an/a3.3×n/a0.0×0.61
SureNano Science Ltd · CSE:SUREUS$1.17MUS$672,321n/an/an/a0.3×n/a0.0×0.25
Valion Bio, Inc. · NASDAQ:VBIOUS$1.04MUS$16.34Mn/a42.8×n/a0.2×n/a4.1×1.11
GeoVax Labs, Inc. · NASDAQ:GOVXUS$985,460−US$915,033n/an/an/a0.9×n/a0.2×1.47
Biodexa Pharmaceuticals plc · NASDAQ:BDRXUS$982,950−US$3.22Mn/an/an/a0.1×n/a0.0×1.01
Gabather AB · OMXSTO:GABAUS$919,514US$559,105n/an/an/a6.4×n/a0.0×n/a
ExpreS2ion Biotech Holding AB · OMXSTO:EXPRS2US$792,634−US$2.43Mn/a−6.5×n/a0.2×−935.9%0.0×n/a
Silexion Therapeutics Corp · NASDAQ:SLXNUS$790,001−US$3.60Mn/an/an/a0.3×n/a0.1×2.77
Oragenics Inc. · AMEX:OGENUS$708,377−US$1.12Mn/an/an/a0.7×n/a0.4×1.47
Protagenic Therapeutics, Inc. · OTC:PTIXUS$687,879US$610,9700.1×n/an/a0.6×n/a0.0×1.21
Lakewood-Amedex Biotherapeutics Inc. · NASDAQ:LABTUS$580,337−US$2.74Mn/an/an/a0.2×n/a0.0×0.46
Median of the othersUS$856,074−US$1.02M0.1×18.1×0.3×−935.9%0.0×1.16

Team and board

Officers

OfficerRole
Mike GuzzettaChairman, President, CEO & CFO

Board

DirectorRole
Mike GuzzettaChairman, President, CEO & CFO
Edward P. McDonoughDirector

Events

QuarterResultsShare move
Q3 2025Nov 13, 2025−2.9%
Q2 2025Aug 13, 20250.0%
Q1 2025May 13, 2025 · Before open+13.6%
Q4 2024Mar 18, 2025 · After close+31.7%
Q3 2024Nov 1, 2024 · Before open+28.1%
Q2 2024Jul 30, 2024 · Before open+28.2%
Q1 2024May 15, 2024 · Before open+11.3%
Q4 2023Mar 20, 2024 · After close−12.6%
Q3 2023Oct 18, 2023 · Before open−10.3%
Q2 2023Jul 14, 2023 · After close+4.8%
All 20 quarters
QuarterResultsShare move
Q1 2023May 2, 2023 · Before open+11.0%
Q4 2022Mar 17, 2023 · After close+3.6%
Q3 2022Oct 31, 2022 · After close+9.6%
Q2 2022Jul 29, 2022 · After close−2.2%
Q1 2022May 10, 2022 · After close−9.5%
Q4 2021Mar 10, 2022−0.5%
Q3 2021Nov 12, 2021−3.2%
Q2 2021Jul 28, 2021+2.5%
Quarter to Mar 31, 2021Apr 16, 2021−2.5%
Quarter to Dec 31, 2020Mar 5, 2021+20.7%

Open Events

Decks

DeckKindSlidesDate
Shareholder Meeting (February 2022)Shareholder meeting24 slidesFeb 11, 2022
Investor Presentation (September 2020)Investor deck26 slidesSeptember 2020
Investor Presentation (June 2019)Investor deck20 slidesJune 2019
Technical Presentation (March 2010)Technical30 slidesMarch 2010

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue0000000000
Cost of revenue52.9K48.3K58.5K3.00K3.00K3.00K3.00K3.00K3.00K
Gross profit-52.9K-48.3K-58.5K-3.00K-3.00K-3.00K-3.00K-3.00K-3.00K
Research and development106.6K99.6K112.4K448.9K435.9K527.3K369.5K337.1K296.5K450.9K
Selling, general and administrative235.7K206.3K254.8K1.40M1.89M7.11M3.83M876.0K1.21M1.07M
Operating income-393.6K-311.0K-367.0K-1.85M-2.33M-7.64M-4.19M-1.22M-1.51M-1.52M
Depreciation and amortization51.3K52.9K48.3K58.5K3.00K3.00K3.00K3.00K3.00K3.00K
EBITDA-342.4K-258.1K-318.7K-1.79M-2.33M-7.64M-4.19M-1.21M-1.51M-1.52M
Interest expense0003061.66K12
Income before tax-393.6K-364.0K-415.0K-1.91M-2.33M-7.64M-4.20M-1.22M-1.51M-1.52M
Income tax0001000000
Net income-393.6K-364.2K-415.5K-1.91M-2.33M-7.64M-4.20M-1.22M-1.51M-1.52M
Earnings per share, basic0.000.00-0.01-0.010.00-0.03-0.020.00-0.01-0.01
Earnings per share, diluted0.000.00-0.01-0.010.00-0.03-0.020.00-0.01-0.01

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents1.12K4.70K20.4K25.6K57.6K193.4K377.4K136.0K302.9K371.0K
Short-term investments000
Receivables0
Inventory000
Current assets2.17K-3.65K21.5K26.6K83.6K194.5K378.4K137.1K365.1K441.4K
Property, plant and equipment000
Goodwill000
Total assets483.4K466.1K480.6K462.9K446.2K469.2K585.9K324.9K518.1K542.1K
Accounts payable185.4K124.0K44.7K41.5K93.3K45.0K2678.9K26.9K45.2K
Current liabilities185.4K124.0K44.7K41.5K93.3K45.0K078.9K144.6K45.3K
Long-term debt000
Total debt117.7K
Total liabilities185.4K124.0K44.7K41.5K93.3K45.0K25.5K78.9K144.6K45.3K
Shareholders' equity297.9K342.1K435.9K421.3K353.0K424.2K560.4K246.0K373.6K496.8K
Shares outstanding406.8M371.9M346.2M322.9M297.4M286.0M275.4M259.8M251.4M238.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-135.4K-223.1K-376.0K-804.7K-889.9K-881.3K-850.7K-453.5K-605.1K-820.3K
Capital spending-56.3K-58.1K-59.2K-132.0K-91.0K-70.2K-25.0K-35.5K-59.0K-29.8K
Free cash flow-191.7K-223.1K-435.1K-936.7K-980.9K-951.5K-875.7K-489.0K-664.1K-850.0K
Cash from investing-56.3K-58.1K-59.2K-132.0K-91.0K-70.2K-25.0K-35.5K57.0K-29.8K
Cash from financing197.5K256.0K430.0K904.7K845.0K767.6K1.12M322.0K480.0K850.0K
Dividends paid000
Share buybacks016820
Change in cash5.82K-25.1K-5.14K-32.0K-135.9K-183.9K241.3K-166.9K-68.1K-43

Open Financials

Cap table

Built by 6ix from ProtoKinetix, Inc.’s releases · as of Sep 2, 2026

Common shares
411,630,152
Fully diluted
411,630,152

Fully diluted

LineSharesAs of
Common shares411,630,152Sep 2, 2026

Share count over time

CountShares
Sep 2, 2026411,630,152

Open Cap table

Shareholders

HolderSharesOf the companyAs of
Williams Jones Wealth Management, LLC.20,000<0.01%Sep 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Mark L. Baum
Other companies: Harrow, Inc. (Chief Executive Officer and Chairman of the Board of Directors · Since at least Dec 12, 2011); Eton Pharmaceuticals, Inc. (Director · Nov 9, 2018 – Mar 12, 2020 · Past); Ideal Power Inc. (Director · Nov 21, 2013 – Mar 3, 2017 · Past)
President, Director · May 28, 2007 – May 28, 2007 · Past
Michael Guzzetta
Other companies: Integral Technologies Inc (CFO · Sep 19, 2018 – Sep 19, 2018 · Past)
Chairman, President, CEO & CFO · Since at least Nov 14, 2017
Clarence E. SmithPresident & CEO, Director · Since at least Nov 2, 2020
Edward P. McDonoughDirector · Since at least Jul 1, 2015
Jason G LampDirector · Since at least Jun 17, 2026
Keith R BruntPresident, Director · Since at least Jun 17, 2026
Michael Winston JonesDirector · Since at least Jun 17, 2026
Ross Laurence SeniorCEO, Director · Sep 12, 2014 – Sep 12, 2014 · Past

Open People

Log in to ask 6ix AI your own questions about ProtoKinetix, Inc.